A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients

Hottinger, Andréas; George, Anne-Claude Catherine; Bel, Michael; Favet, Laurence; Combescure, Christophe; Meier, Sara; Grillet, Stéphane; Posfay Barbe, Klara; Kaiser, Laurent; Siegrist, Claire-Anne; Dietrich, Pierre-Yves

doi:10.1634/theoncologist.2011-0342

Advanced search

Browse by...

Deposit

Highlights

More informations

Title		A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients
Authors		Hottinger, Andréas George, Anne-Claude Catherine Bel, Michael Favet, Laurence Combescure, Christophe Meier, Sara Grillet, Stéphane Posfay Barbe, Klara Kaiser, Laurent Siegrist, Claire-Anne Dietrich, Pierre-Yves show all authors [1 - 11]
Published in		The Oncologist. 2012, vol. 17, no. 3, p. 436-45
Abstract		To identify the determinants of antibody responses to adjuvanted influenza A/H1N1/09 vaccines in a cohort of cancer outpatients.
Keywords		Age Factors — Aged — Aged, 80 and over — Antibodies/blood/immunology — Antibody Formation/immunology — Female — Humans — Influenza A Virus, H1N1 Subtype/immunology — Influenza Vaccines/administration & dosage/immunology — Influenza, Human/complications/prevention & control — Male — Middle Aged — Neoplasms/complications — Outpatients — Prospective Studies — Sex Factors
Identifiers		DOI: 10.1634/theoncologist.2011-0342 PMID: 22357731
Full text		Article (Published version) (472 Kb) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique
Research groups		Centre de vaccinologie et d'immunologie néonatale (177) Epidémiologie clinique (115) Groupe Laurent Kaiser (virologie clinique) (668) Recherche en infectiologie pédiatrique et en pédiatrie générale (853) Immunothérapie des cancers (42)
Citation (ISO format)		HOTTINGER, Andréas et al. A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients. In: The Oncologist, 2012, vol. 17, n° 3, p. 436-45. doi: 10.1634/theoncologist.2011-0342 https://archive-ouverte.unige.ch/unige:31657